Docs back moratorium on drug ads: survey

Share this article:
A solid majority of doctors - 64% - say there should be some sort of moratorium on DTC advertising, according to a survey by TNS Healthcare.

Almost half of physicians - 44% - would approve of a moratorium of two years or more, and 27% believe there should be no DTC ads at all.

The survey of 1,002 physicians and 251 consumers found physician attitudes toward DTC far harsher than those of the general public. Only 44% of consumers favored a moratorium on drug ads, with 41% backing a two-year moratorium and 32% saying there should be no drug advertising at all.

Physicians and consumers were in agreement that the FDA is falling down on the job of policing DTC, with three-quarters of both groups saying the agency has failed to adequately vet ads.

Share this article:

Email Newsletters

More in News

BI rethinks hepatitis business, posts 2013 results

BI rethinks hepatitis business, posts 2013 results

Boehringer Ingelheim says it is no longer pursuing an interferon-free combination of faldaprevir and deleobuvir.

Roche wraps quarter with two fewer pipeline medications

Roche wraps quarter with two fewer pipeline medications

Roche also announced first-quarter sales shrank 1%.

2013 favored specialists, specialty Rx

2013 favored specialists, specialty Rx

The latest IMS Institute for Healthcare Informatics assessment of 2013's prescription drug use shows that 2.3% of prescriptions account for 30% of a patient's out-of-pocket prescription costs.